Search Results - "Jamka, Leslie P."
-
1
Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso
Published in International journal of infectious diseases (01-01-2021)“…•This is the first study on the co-administration of typhoid conjugate vaccine (TCV) in West Africa.•Co-administration of TCV with routine vaccines in a…”
Get full text
Journal Article -
2
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
Published in International journal of infectious diseases (01-07-2021)“…•This is the first study on the co-administration of typhoid conjugate vaccine (TCV) in West Africa.•Co-administration of TCV with routine vaccines in a…”
Get full text
Journal Article -
3
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
Published in Human vaccines & immunotherapeutics (31-12-2024)“…Vaccine safety and immunogenicity data in human immunodeficiency virus (HIV)-exposed uninfected (HEU) children are important for decision-making in HIV and…”
Get full text
Journal Article -
4
A Description of the Statistical Methods for the Vaccine Impact on Diarrhea in Africa (VIDA) Study
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background Diarrheal diseases remain a health threat to children in low- and middle-income countries. The Vaccine Impact on Diarrhea in Africa (VIDA)…”
Get full text
Journal Article -
5
Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007–2011) and the Vaccine Impact of Diarrhea in Africa (VIDA) Study (2015–2018)
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background Reducing diarrhea-related morbidity and mortality is a global priority, particularly in low-resource settings. We assessed adherence to…”
Get full text
Journal Article -
6
Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomised controlled trial in Malawian children
Published in The Lancet (British edition) (03-02-2024)“…Randomised controlled trials of typhoid conjugate vaccines among children in Africa and Asia have shown high short-term efficacy. Data on the durability of…”
Get full text
Journal Article -
7
Clinical and Epidemiologic Features of Cryptosporidium-Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background As part of the Vaccine Impact on Diarrhea in Africa (VIDA) Study, we examined the prevalence, clinical presentation, and seasonality of…”
Get full text
Journal Article -
8
Moderate-to-Severe Diarrhea and Stunting Among Children Younger Than 5 Years: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background Stunting affects >20% of children <5 years old worldwide and disproportionately impacts underserved communities. The Vaccine Impact on…”
Get full text
Journal Article -
9
Antibiotic-Prescribing Practices for Management of Childhood Diarrhea in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015–2018
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background Despite antibiotic prescription being recommended for dysentery and suspected cholera only, diarrhea still triggers unwarranted antibiotic…”
Get full text
Journal Article -
10
Using Typhoid Conjugate Vaccines to Prevent Disease, Promote Health Equity, and Counter Drug-Resistant Typhoid Fever
Published in Open forum infectious diseases (02-06-2023)“…Abstract Typhoid fever is a serious disease that disproportionately impacts children in low-resource settings in sub-Saharan Africa, South and Southeast Asia,…”
Get full text
Journal Article -
11
Norovirus Disease Among Children <5 Years in 3 Sub-Saharan African Countries: Findings From the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015–2018
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background To address a paucity of data from sub-Saharan Africa, we examined the prevalence, severity, and seasonality of norovirus genogroup II…”
Get full text
Journal Article -
12
Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background While rotavirus causes severe diarrheal disease in children aged <5 years, data on other viral causes in sub-Saharan Africa are limited…”
Get full text
Journal Article -
13
Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin–Producing Escherichia coli Among Children Aged <5 Years in 3 Countries in Africa, 2015–2018: Vaccine Impact on Diarrhea in Africa (VIDA) Study
Published in Clinical infectious diseases (19-04-2023)“…Abstract Background To address knowledge gaps regarding diarrheagenic Escherichia coli (DEC) in Africa, we assessed the clinical and epidemiological features…”
Get full text
Journal Article -
14
Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data
Published in The Lancet global health (01-01-2023)“…Typhoid conjugate vaccines are being introduced in low-income and middle-income countries to prevent typhoid illness in children. Vaccine effectiveness studies…”
Get full text
Journal Article -
15
Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
Published in Clinical infectious diseases (07-03-2019)“…Abstract The health consequences of typhoid, including increasing prevalence of drug-resistant strains, can stress healthcare systems. While vaccination is one…”
Get full text
Journal Article -
16
A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper
Published in Clinical infectious diseases (07-03-2019)“…Abstract The recent Typhoid Fever Surveillance in Africa Program demonstrated an overall adjusted incidence of typhoid fever 2–3 times higher than previous…”
Get full text
Journal Article -
17
Durable Anti-Vi IgG and IgA Antibody Responses in 15-Month-Old Children Vaccinated With Typhoid Conjugate Vaccine in Burkina Faso
Published in Journal of the Pediatric Infectious Diseases Society (27-09-2023)“…Abstract We assessed anti-Vi IgG/IgA responses to typhoid conjugate vaccine (TCV) in children enrolled in a double-blind randomized controlled, phase 2 trial…”
Get full text
Journal Article